BIOMIRA RESEARCH (BIOM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOMIRA RESEARCH (BIOM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chirodoc who wrote (32)	1/10/2000 1:54:00 AM
From: chirodoc	Read Replies (1) of 72

Biomira Maintained Near-Term `Buy' at Merrill Toronto, Jan. 7 (Bloomberg Data) -- Biomira Inc. (BRA CN) was maintained near-term ``buy' by analyst Andre Uddin at Merrill Lynch & Co. The 12-month target price is US$ 6.50 per share. NYSE/AMEX delayed 20 min. NASDAQ delayed 15 min.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next